Abstract:Mouse models are the basis of preclinical and translational research in solid tumors. Multiple methods exist to induce tumor formation in mice, including genetically engineered mouse models, chemotoxic agents, injection of tumor cells, and xenograft approaches. Synovial sarcoma, a rare highly malignant soft-tissue tumor, poses a serious threat to patients due to its aggressive nature and associated high rates of mortality and morbidity. This disease's underlying cause and development remain poorly comprehended, and existing treatment approaches have yielded unsatisfactory outcomes. In the last two decades, numerous effective animal models of soft tissue sarcoma (STS) have been created, primarily utilizing genetically engineered mice and zebrafish, however long latency of tumor development for several months in these models creates a barrier for practical in-vivo experiments for drug testing or manipulating the cellular composition of the tumor microenvironment. In studying cancer immunotherapy, it is important to consider aspects of antitumor immune responses and to produce a model that mimics the complexity of the immune system We have generated a new mouse model of synovial sarcoma of exceptionally fast tumor development. Intramuscular delivery of Cre recombinase protein in mice which drives conditional knockdown in PTEN, stabilization of β-catenin, and formation of fusion oncogenes of SS18-SSX2 was sufficient to initiate high-grade synovial sarcomas with myofibroblastic differentiation in 3 weeks. As immunotherapy is increasingly applied to sarcomas, our mouse model will serve as a great tool for preclinical data. Flow cytometry-based analysis of peripheral blood shows significant changes in immune cell populations as early as five days after Tat-Cre injection and continues throughout the development of synovial sarcoma. These results suggest a significant systemic phenotypic alteration of circulating immune cells, which may impact other major organs in this genetic mouse model of synovial sarcoma. Single- cell RNA sequencing of the CD45+ leukocytes in the tumor microenvironment reveals subsets that may promote tumor progression. Our work promises to significantly enhance our understanding of the pathogenesis of this disease and establish a reliable preclinical platform for devising and assessing therapeutic interventions. Citation Format: Hesham Mohei, Donn Van Deren, Irene S. Molina, Malay Haldar. New insights from a novel mouse model of synovial sarcoma [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Tumor-body Interactions: The Roles of Micro- and Macroenvironment in Cancer; 2024 Nov 17-20; Boston, MA. Philadelphia (PA): AACR; Cancer Res 2024;84(22_Suppl) nr C008.

A humanised rat model of osteosarcoma reveals ultrastructural differences between bone and mineralised tumour tissue

Establishment of Reproducible Osteosarcoma Rat Model Using Orthotopic Implantation Technique.

Establishment of humanised xenograft models as in vivo study for lung metastasis of osteosarcoma

An Orthotopic Model of Human Osteosarcoma Growth and Spontaneous Pulmonary Metastasis

Establishment of orthotopic osteosarcoma animal models in immunocompetent rats through muti-rounds of in-vivo selection

Establishment and characterization of in vivo orthotopic bioluminescent xenograft models from human osteosarcoma cell lines in Swiss nude and NSG mice

Engineered bone marrow as a clinically relevant ex vivo model for primary bone cancer research and drug screening

A Novel Animal Model for Bone Metastasis in Human Lung Cancer

A nude mouse model of human osteosarcoma lung metastases for evaluating new therapeutic strategies

An osteosarcoma-on-a-chip model for studying osteosarcoma matrix-cell interactions and drug responses

Optimization of the chicken chorioallantoic membrane assay as reliable in vivo model for the analysis of osteosarcoma

Establishment of Patient-Derived Xenograft Mouse Model with Human Osteosarcoma Tissues

Establishment of an Orthotopic Transplantation Model of Human Osteosarcoma and a Study of Its Biological Behavior

XactMice: Humanizing Mouse Bone Marrow Enables Microenvironment Reconstitution in a Patient-Derived Xenograft Model of Head and Neck Cancer.

A Xenograft and Cell Line Model of SDH-deficient Pheochromocytoma Derived from Sdhb+/− Rats

Patient-derived Human Tumour Tissue Xenografts in Immunodeficient Mice: a Systematic Review

A Novel Brain Metastases Model Developed in Immunodeficient Rats Closely Mimics the Growth of Metastatic Brain Tumours in Patients

Modeling Spontaneous Bone Metastasis Formation of Solid Human Tumor Xenografts in Mice

Characterization of different osteosarcoma phenotypes by PET imaging in preclinical animal models

Abstract C008: New insights from a novel mouse model of synovial sarcoma

Advances of Osteosarcoma Models for Drug Discovery and Precision Medicine